HIV and Cardiovascular Disease — An Ounce of Prevention
Persons with human immunodeficiency virus (HIV) infection have up to two times the risk of cardiovascular disease as those without HIV infection. 1 This risk is not explained by the presence of risk factors for atherosclerotic cardiovascular disease, nor is it eliminated by successful antiretroviral...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2023-08, Vol.389 (8), p.760-761 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 761 |
|---|---|
| container_issue | 8 |
| container_start_page | 760 |
| container_title | The New England journal of medicine |
| container_volume | 389 |
| creator | Freiberg, Matthew S. |
| description | Persons with human immunodeficiency virus (HIV) infection have up to two times the risk of cardiovascular disease as those without HIV infection.
1
This risk is not explained by the presence of risk factors for atherosclerotic cardiovascular disease, nor is it eliminated by successful antiretroviral therapy and viral suppression.
2
Assessing cardiovascular risk among persons with HIV infection has proved to be difficult because calculators for cardiovascular disease typically underestimate the risk in this population.
3
This underestimation creates a challenge for health care providers. How can cardiovascular risk be reduced in a population that is assessed as being at low-to-moderate risk on . . . |
| doi_str_mv | 10.1056/NEJMe2306782 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2841404462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2841404462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-b34df0d32cec5d7460824dc0f22a984ea41e547b4e9614f461f1edca40e265d33</originalsourceid><addsrcrecordid>eNpt0M1Kw0AUBeBBFFurO9cyoAsXRufnZpIsS61WqdaFug3TmRtIaSZ1pim48yF8Qp_ESKuIeDd383E4HEIOOTvnLFYX98PbOxSSqSQVW6TLYykjAKa2SZcxkUaQZLJD9kKYsfY4ZLukIxNIVRKLLslGN89UO0sH2tuyXulgmrn29LIMqAPSj7d32nd00jiDtC7og8cVumVZu32yU-h5wIPN75Gnq-HjYBSNJ9c3g_44MhLSZTSVYAtmpTBoYpuAYqkAa1ghhM5SQA0cY0imgJniUIDiBUdrNDAUKrZS9sjpOnfh65cGwzKvymBwPtcO6ybkIgUODECJlh7_obO68a5t16pYgWQ8hladrZXxdQgei3zhy0r715yz_GvS_PekLT_ahDbTCu0P_t6wBSdrUFUhdzir_s_5BFbTeeI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2856430154</pqid></control><display><type>article</type><title>HIV and Cardiovascular Disease — An Ounce of Prevention</title><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Freiberg, Matthew S.</creator><creatorcontrib>Freiberg, Matthew S.</creatorcontrib><description>Persons with human immunodeficiency virus (HIV) infection have up to two times the risk of cardiovascular disease as those without HIV infection.
1
This risk is not explained by the presence of risk factors for atherosclerotic cardiovascular disease, nor is it eliminated by successful antiretroviral therapy and viral suppression.
2
Assessing cardiovascular risk among persons with HIV infection has proved to be difficult because calculators for cardiovascular disease typically underestimate the risk in this population.
3
This underestimation creates a challenge for health care providers. How can cardiovascular risk be reduced in a population that is assessed as being at low-to-moderate risk on . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMe2306782</identifier><identifier>PMID: 37486752</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>AIDS ; Alcohol ; Allergy ; Antiretroviral therapy ; Arteriosclerosis ; Atherosclerosis ; Cardiology ; Cardiology General ; Cardiovascular disease ; Cardiovascular diseases ; Cholesterol ; Coronary Disease ; Disease prevention ; Drug therapy ; Hepatitis C ; HIV ; Human immunodeficiency virus ; Immunology ; Infections ; Infectious Disease ; Inflammation ; Inflammatory Disease ; Lipids ; Low density lipoprotein ; Myocardial Infarction ; Prevention ; Risk factors ; Statins</subject><ispartof>The New England journal of medicine, 2023-08, Vol.389 (8), p.760-761</ispartof><rights>Copyright © 2023 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c348t-b34df0d32cec5d7460824dc0f22a984ea41e547b4e9614f461f1edca40e265d33</citedby><cites>FETCH-LOGICAL-c348t-b34df0d32cec5d7460824dc0f22a984ea41e547b4e9614f461f1edca40e265d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMe2306782$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2856430154?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,2759,2760,26103,27924,27925,52382,54064,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37486752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Freiberg, Matthew S.</creatorcontrib><title>HIV and Cardiovascular Disease — An Ounce of Prevention</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Persons with human immunodeficiency virus (HIV) infection have up to two times the risk of cardiovascular disease as those without HIV infection.
1
This risk is not explained by the presence of risk factors for atherosclerotic cardiovascular disease, nor is it eliminated by successful antiretroviral therapy and viral suppression.
2
Assessing cardiovascular risk among persons with HIV infection has proved to be difficult because calculators for cardiovascular disease typically underestimate the risk in this population.
3
This underestimation creates a challenge for health care providers. How can cardiovascular risk be reduced in a population that is assessed as being at low-to-moderate risk on . . .</description><subject>AIDS</subject><subject>Alcohol</subject><subject>Allergy</subject><subject>Antiretroviral therapy</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Cardiology</subject><subject>Cardiology General</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cholesterol</subject><subject>Coronary Disease</subject><subject>Disease prevention</subject><subject>Drug therapy</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immunology</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Inflammation</subject><subject>Inflammatory Disease</subject><subject>Lipids</subject><subject>Low density lipoprotein</subject><subject>Myocardial Infarction</subject><subject>Prevention</subject><subject>Risk factors</subject><subject>Statins</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0M1Kw0AUBeBBFFurO9cyoAsXRufnZpIsS61WqdaFug3TmRtIaSZ1pim48yF8Qp_ESKuIeDd383E4HEIOOTvnLFYX98PbOxSSqSQVW6TLYykjAKa2SZcxkUaQZLJD9kKYsfY4ZLukIxNIVRKLLslGN89UO0sH2tuyXulgmrn29LIMqAPSj7d32nd00jiDtC7og8cVumVZu32yU-h5wIPN75Gnq-HjYBSNJ9c3g_44MhLSZTSVYAtmpTBoYpuAYqkAa1ghhM5SQA0cY0imgJniUIDiBUdrNDAUKrZS9sjpOnfh65cGwzKvymBwPtcO6ybkIgUODECJlh7_obO68a5t16pYgWQ8hladrZXxdQgei3zhy0r715yz_GvS_PekLT_ahDbTCu0P_t6wBSdrUFUhdzir_s_5BFbTeeI</recordid><startdate>20230824</startdate><enddate>20230824</enddate><creator>Freiberg, Matthew S.</creator><general>Massachusetts Medical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20230824</creationdate><title>HIV and Cardiovascular Disease — An Ounce of Prevention</title><author>Freiberg, Matthew S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-b34df0d32cec5d7460824dc0f22a984ea41e547b4e9614f461f1edca40e265d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>AIDS</topic><topic>Alcohol</topic><topic>Allergy</topic><topic>Antiretroviral therapy</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Cardiology</topic><topic>Cardiology General</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cholesterol</topic><topic>Coronary Disease</topic><topic>Disease prevention</topic><topic>Drug therapy</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immunology</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Inflammation</topic><topic>Inflammatory Disease</topic><topic>Lipids</topic><topic>Low density lipoprotein</topic><topic>Myocardial Infarction</topic><topic>Prevention</topic><topic>Risk factors</topic><topic>Statins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Freiberg, Matthew S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Freiberg, Matthew S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIV and Cardiovascular Disease — An Ounce of Prevention</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2023-08-24</date><risdate>2023</risdate><volume>389</volume><issue>8</issue><spage>760</spage><epage>761</epage><pages>760-761</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Persons with human immunodeficiency virus (HIV) infection have up to two times the risk of cardiovascular disease as those without HIV infection.
1
This risk is not explained by the presence of risk factors for atherosclerotic cardiovascular disease, nor is it eliminated by successful antiretroviral therapy and viral suppression.
2
Assessing cardiovascular risk among persons with HIV infection has proved to be difficult because calculators for cardiovascular disease typically underestimate the risk in this population.
3
This underestimation creates a challenge for health care providers. How can cardiovascular risk be reduced in a population that is assessed as being at low-to-moderate risk on . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>37486752</pmid><doi>10.1056/NEJMe2306782</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2023-08, Vol.389 (8), p.760-761 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2841404462 |
| source | EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | AIDS Alcohol Allergy Antiretroviral therapy Arteriosclerosis Atherosclerosis Cardiology Cardiology General Cardiovascular disease Cardiovascular diseases Cholesterol Coronary Disease Disease prevention Drug therapy Hepatitis C HIV Human immunodeficiency virus Immunology Infections Infectious Disease Inflammation Inflammatory Disease Lipids Low density lipoprotein Myocardial Infarction Prevention Risk factors Statins |
| title | HIV and Cardiovascular Disease — An Ounce of Prevention |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T15%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIV%20and%20Cardiovascular%20Disease%20%E2%80%94%20An%20Ounce%20of%20Prevention&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Freiberg,%20Matthew%20S.&rft.date=2023-08-24&rft.volume=389&rft.issue=8&rft.spage=760&rft.epage=761&rft.pages=760-761&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMe2306782&rft_dat=%3Cproquest_cross%3E2841404462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2856430154&rft_id=info:pmid/37486752&rfr_iscdi=true |